Ole-Petter Riksfjord Hamnvik

8PUBLICATIONS
22CO-AUTHORS
Molecular targetsTransgender studiesCancer therapy (excl. chemotherapy and radiation therapy)ReproductionCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2026
Ersodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors.

|Jun 06, 2025
Breast cancer in a transgender man.

Alison May Berner, Tristan Michael MacKenzie, Shirish Kulkarni

|Mar 04, 2025
Management of vasomotor symptoms in cancer patients.

Ling Zhu, Tammy T Hshieh, Tara K Iyer

|Dec 30, 2024
Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy.

Micol S Rothman, Ole-Petter R Hamnvik, Caroline Davidge-Pitts

|Jan 13, 2022
Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.

Yee-Ming Melody Cheung, Wei Wang, Bradley McGregor

Pageof 2